Leading the way in Europe to bring microbiome-based innovations to market.
News
Caelus Receives a Positive EFSA Safety Opinion Under the EU Novel Food Regulation for its Pioneering Gut Bacterium
Anaerobutyricum soehngenii is the first live, gut-native bacterium of its kind to receive a positive EFSA safety opinion under the EU Novel Food Regulation, an important step toward reaching European consumers. DELFT, the Netherlands, 1 September 2026. Caelus welcomes...
European Microbiome Innovation for Health (EMIH) brings together innovative leading European stakeholders dedicated to advancing the microbiome industry.
Our mission
The goal of the EMIH is to promote medical innovation, based on the microbiota, as one of the public health priorities within the European Union. Its members are committed to developing advances in therapeutic, diagnostics and medical bioproduction based on the microbiota, in the field of human health, through a framework meeting the highest quality standards and also allowing economic balance, in order to maintain therapeutic innovation.
About us
EMIH gathers more than 20 key private and public players supporting each other’s efforts to develop tomorrow’s medicine based on microbiome diagnostic and therapeutic innovations.
EMIH is collectively building a dynamic ecosystem to advance medical innovation centered on the microbiota, prioritizing public health within the EU and addressing unmet medical needs to enhance the quality of life for millions of patients.
Our members
EMIH brings together more than 30+ key private and public players committed to develop tomorrow’s medicine based on microbiome diagnostic and therapeutic innovations.
Join us!
Unity is strength. Joining EMIH means being able to provide input to policy makers, patients’ associations, investors in Europe, and share networking opportunities while contributing to structure the industry.
News
Caelus Receives a Positive EFSA Safety Opinion Under the EU Novel Food Regulation for its Pioneering Gut Bacterium
> READ
Mikrobiomik Obtains Authorization for EUTEGRA® in Spain Under the National Spanish SoHO Framework, Ahead of EU SoHO Application in August 2027
> READ